Summary
Global Data's clinical trial report, "Glaucoma Global Clinical Trials
Review, H1, 2015" provides an overview of Glaucoma clinical trials
scenario. This report provides top line data relating to the clinical trials on
Glaucoma. Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe. The report offers
coverage of disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also provides
prominent drugs for in-progress trials (based on number of ongoing trials).
Global Data Clinical Trial Reports are generated using Global Data's
proprietary database - Pharma eTrack Clinical trials database. Clinical trials
are collated from 80+ different clinical trial registries, conferences,
journals, news etc across the globe. Clinical trials database undergoes
periodic update by dynamic process.
Browse
Detail Report With TOC @ http://www.hexareports.com/report/glaucoma-global-clinical-trials-review-h1-2015/details
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End
point status
- The report reviews top companies involved and enlists all trials (Trial
title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Table of
Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Glaucoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and
Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South
America 14
Request
A Sample copy of This Report @ http://www.hexareports.com/sample/42404
Clinical Trials by
G7 Countries: Proportion of Glaucoma to Ophthalmology Clinical Trials 15
Clinical Trials by
Phase in G7 Countries 16
Clinical Trials in
G7 Countries by Trial Status 17
Clinical Trials by
E7 Countries: Proportion of Glaucoma to Ophthalmology Clinical Trials 18
Clinical Trials by
Phase in E7 Countries 19
Clinical Trials in
E7 Countries by Trial Status 20
Clinical Trials by
Phase 21
In Progress Trials
by Phase 22
Clinical Trials by
Trial Status 23
Clinical Trials by
End Point Status 24
Unaccomplished
Trials of Glaucoma 25
Subjects Recruited
Over a Period of Time 30
Clinical Trials by
Sponsor Type 31
Prominent Sponsors
32
Top Companies
Participating in Glaucoma Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical
Trials News on Glaucoma 35
May 11, 2015:
Isarna Presents Positive Preclinical Results Supporting Development of ISTH0036
for the Treatment of Glaucoma 35
May 11, 2015:
Promising preclinical data on NCX 667 for glaucoma presented at ARVO by Nicox
35
May 11, 2015:
Promising preclinical data on NCX 470 for glaucoma presented at ARVO by Nicox
36
Apr 28, 2015:
Avalanche Biotechnologies to Present at Upcoming Scientific Meetings 36
Apr 16, 2015:
Isarna Initiates First-in-Human Phase I Trial for ISTH0036 to Treat Advanced
Glaucoma 37
Mar 24, 2015: Aerie
Pharmaceuticals Completes Enrollment in Second Phase 3 Registration Trial of
Rhopressa, Novel Triple-Action Product to Lower Intraocular Pressure in
Patients with Glaucoma 37
Clinical Trial
Profiles 39
Clinical Trial
Overview of Top Companies 39
Novartis AG 39
Clinical Trial
Overview of Novartis AG 39
Actavis plc 47
Clinical Trial
Overview of Actavis plc 47
Pfizer Inc. 53
Clinical Trial
Overview of Pfizer Inc. 53
Santen
Pharmaceutical Co., Ltd. 57
Browse
Full Report @ http://www.hexareports.com/report/glaucoma-global-clinical-trials-review-h1-2015/details
About Us:
Hexa Reports is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact
Information:
Ryan
Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone
Number
1-800-489-3075
Email
Us: sales@hexareports.com
Our
Website: http://www.hexareports.com/
No comments:
Post a Comment